FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News

FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News: A new Alzheimer's treatment slows progression of the disease, the drug’s developers say. But some researchers question its effectiveness.

Comments

Post a Comment

Popular posts from this blog

The conflict in Gaza: a view from Israel - The Lancet

The conflict in Gaza: a view from Israel - The Lancet : Khamis Elessi1 writes as a physician describing the deteriorating situation in the Gaza Strip (or Gaza) and pleads to save the residents of Gaza from catastrophe. We share his concern for all the innocent people in Israel and in Gaza. Unfortunately, his Correspondence contains inaccuracies and omits information that paints a very different picture of the catastrophe and its causes.
Read more

George F. Will - Skip the lecture on Israel's 'risks for peace'

By George F. Will Thursday, August 19, 2010 JERUSALEM In the intifada that began in 2000, Palestinian terrorism killed more than 1,000 Israelis. As a portion of U.S. population, that would be 42,000, approaching the toll of America's eight years in Vietnam. During the onslaught, which began 10 Septembers ago, Israeli parents sending two children to a school would put them on separate buses to decrease the chance that neither would return for dinner. Surely most Americans can imagine, even if their tone-deaf leaders cannot, how grating it is when those leaders lecture Israel on the need to take "risks for peace." During Prime Minister Binyamin Netanyahu's July visit to Washington, Barack Obama praised him as " willing to take risks for peace ." There was a time when that meant swapping "land for peace" -- Israel sacrificing something tangible and irrecoverable, strategic depth, in exchange for something intangible and perisha...
Read more